Lost password ?
The typical manufacturing process of monoclonal antibodies (mAb) includes 2 to 3 chromatography steps for capture, intermediate purification and polishing. Concentration and diafiltration based on tangential flow filtration are also common steps of mAb downstream processing.
Novasep can provide you with chromatography systems, TFF solutions, and associated process development services for the manufacturing of monoclonal antibodies.
Downstream processing is recognized as the bottleneck of mAb manufacturing, characterized by a high Cost of Goods (for example due to protein-A resins) and by discontinuous batch-based operations.
With the BioSC™, our new continuous chromatography technology, you will reap significant benefits compared to batch chromatography, including:
With the BioSC™, the process can be adapted to your process development strategy to generate the most competitive and efficient operation unit.
The BioSC™ is also the perfect solution when you start considering switching to semi- or fully-continuous downstream processes for mAb manufacturing.
Learn more about our BioSC™ technology.
The Prochrom®-Bio range is a chromatography technology that is perfect for intermediary purification and polishing steps of monoclonal antibodies. It is based on the Prochrom® technology, recognized as the market reference for industrial chromatography.
Prochrom®-Bio is characterized by competitive assets:
Learn more about our Prochrom®-Bio technology.
For clarification, concentration and diafiltration, tangential flow filtration remains an important technology for mAb downstream processing. Novasep can provide you industrial TFF systems adapted to your needs.
